P2RX4 and depressive symptom measurement: The involvement of P2X4R is further examined using ivermectin (IVM), a selective P2X4R agonist.<h4>Results</h4>LIPUS significantly alleviates the LPS-induced depression-like behavior, suppresses hippocampal pro-inflammatory cytokine expression, inhibits microglial activation, and reduces neuronal apoptosis.